PBS Biotech Joins Organoid COMMONS to Accelerate Industrialization and Scalability of Human-Relevant Models

This press release announces PBS Biotech's membership in Organoid COMMONS, an industry consortium focused on advancing the standardization, industrialization, and commercial scalability of organoid technologies. The document outlines the consortium’s mission to bridge academic innovation and industrial adoption while supporting development of reproducible human-relevant models that may reduce reliance on animal testing. PBS Biotech highlights its contribution of bioprocess expertise, Vertical-Wheel bioreactor technology, and scalable manufacturing solutions designed to improve organoid yield, viability, consistency, and process scalability. Through participation in the consortium, PBS Biotech aims to help establish manufacturing standards, share process knowledge, and support broader adoption of organoid technologies across drug discovery, regenerative medicine, and biopharmaceutical development.